相关实验视频

Updated: Sep 9, 2025

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

在瘤治疗中探索抗体和药物结合物的实验和体方法

Vitor Martins de Almeida¹, Milena Botelho Pereira Soares^2,3, Osvaldo Andrade Santos-Filho¹

¹Laboratory of Molecular Modeling and Computational Structural Biology, Walter Mors Natural Products Research Institute, Health Science Center, Federal University of Rio de Janeiro, Av. Carlos Chagas Filho, 373, Bloco H, Cidade Universitária, Rio de Janeiro 21941-599, RJ, Brazil.

Pharmaceuticals (Basel, Switzerland)

|August 28, 2025

概括

抗体与药物结合剂 (ADC) 结合了针对性抗体与强效药物进行癌症治疗. 结合实验和计算方法,优化ADC设计以提高疗效和更广泛的治疗应用.

科学领域:

癌症学
生物技术
计算化学

背景情况:

抗体与药物结合剂 (ADC) 是癌症治疗的重大进展.
它们利用单克隆抗体对有力细胞毒药物进行向的输送.

研究的目的:

审查ADC设计中的实验和计算进步.
专注于结构元素和优化策略以提高治疗效果.

主要方法:

检查ADC作用机制,抗体工程,链接器化学和有效载荷选择的最新进展.
强调实验策略和计算工具,包括分子建模和人工智能驱动的结构预测.

主要成果:

针对药物输送和旁观者效应,ADC使用了内部化依赖和独立的机制.
关键的有效性因素包括抗原特异性,链接器稳定性和有效载荷强度.
计算方法对于抗体建模,可开发性评估以及在优化中加速候选物选择至关重要.

结论:

综合实验和体方法可以提高ADC的选择性,稳定性和有效性.
这些综合策略对于开发下一代ADC具有增强的治疗指数和更广泛的临床效用至关重要.

关键词:

ADC 的设计抗体与药物结合物癌症连接器分子建模有效载荷针对性的治疗

更多相关视频

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...